THE ORIGINAL INVESTIGATION OF PSILOCYBIN OCCASIONED MYSTICAL-TYPE EXPERIENCES HAS BEEN PUBLISHED IN PSYCHOPHARMACOLOGY

The study was conducted by Dr. Roland Griffiths and his co-researchers at the Johns Hopkins University School of Medicine.

Dr. Griffiths is currently engaged in a Psilocybin study designed to ameliorate the symptoms of anxiety and depression in those facing a diagnosis of life threatening cancer. The study is open and actively recruiting patients.